- AU$206.36m
- AU$169.56m
- AU$387.35m
Deals of the day-Mergers and acquisitions
Brief: Mayne Pharma Says Supreme Court Dismisses Cosette Appeal
Deals of the day-Mergers and acquisitions
Australian court dismisses Cosette appeal to drop Mayne Pharma takeover (updated)
Australian court dismisses Cosette appeal to drop Mayne Pharma takeover
Brief: Mayne Pharma Seeks Trading Halt
Brief: Mayne Pharma Group Fulfils Imvexxy Post-Marketing Study Requirements
Australia's Mayne Pharma rises after settling patent litigation with India's Sun Pharma
Brief: Mayne Pharma Settles US Patent Litigation on Imvexxy With Sun Pharma
Brief: Mayne Pharma Group Signs Licence Agreement For Blissel In Australia
Australia's Mayne Pharma falls on lower unaudited revenue and earnings
Brief: Mayne Pharma Group Appoints Griffin D. Buchanan As CFO
Australia's Mayne Pharma rises on $10.3 million legal costs award
Brief: Mayne Pharma Group Receives A$14.4 MLN Payment For Legal Costs From Cosette
Brief: Mayne Pharma Says Distributerx To Exclusively Distribute Recedo Gel For Resilia Pharmaceuticals
Brief: Mayne Pharma Group Says Court Awards It A$13.27M For Legal Costs From Cosette
Australia's Mayne Pharma jumps after legal cost award
Brief: Mayne Pharma Provides Further Details On Equity Instruments To Be Issued To CEO
Australia's Mayne Pharma gains as quarterly loss narrows